Tech Company Financing Transactions
HepatoChem Funding Round
HepatoChem closed a $330 thousand funding round on 4/26/2012. Investors included Massachusetts Life Sciences Center.
Transaction Overview
Company Name
Announced On
4/26/2012
Transaction Type
Debt
Amount
$330,000
Round
Undisclosed
Investors
Proceeds Purpose
The focus of the current two employees is on adding equipment and capacity, and the company wants to add chemist and business development staff for continued customer acquisition and revenue expansion.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
100 Cummings Center 451C
Cambridge, MA 01915
USA
Cambridge, MA 01915
USA
Phone
Website
Email Address
Overview
HepatoChem develops and commercializes tools for metabolite synthesis, drug discovery, fluorination and catalysis kits.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Financial Officer
Marie Landel
President
Marc Bazin
VP - Bus. Development
Jean-Marie Vallet
Browse more venture capital transactions:
Prev: 4/26/2012: Perk Dynamics venture capital transaction
Next: 4/26/2012: HitPost venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs